Journal article
Anti-Lymphoma Monoclonal Antibodies: Making Better Antibodies and Making Antibodies Better
Transactions of the American Clinical and Climatological Association, Vol.126, pp.87-92
2015
PMCID: PMC4530715
PMID: 26330662
Abstract
Monoclonal antibodies (mAbs) are highly effective anti-cancer agents; however, there is still considerable room for improving their therapeutic impact. Understanding the mechanisms of action of anti-cancer mAbs, and modifying mAb structure based on this understanding, is leading to the design and testing of more effective mAbs.
Details
- Title: Subtitle
- Anti-Lymphoma Monoclonal Antibodies: Making Better Antibodies and Making Antibodies Better
- Creators
- George J Weiner - Iowa City, Iowa
- Resource Type
- Journal article
- Publication Details
- Transactions of the American Clinical and Climatological Association, Vol.126, pp.87-92
- Publisher
- American Clinical and Climatological Association
- PMID
- 26330662
- PMCID
- PMC4530715
- ISSN
- 0065-7778
- Language
- English
- Date published
- 2015
- Academic Unit
- Hematology, Oncology, and Blood & Marrow Transplantation; Pharmaceutical Sciences and Experimental Therapeutics; Internal Medicine
- Record Identifier
- 9984094747602771
Metrics
23 Record Views